öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÕÅ־ΰ
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º31

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º Éó¤Ç°ÁÐÏÙ¼²²¡ÕïÖΣ¬ÓÈÆäרעǰÁÐÏÙØà³ýÊõ£¨¼¤¹âºÍµÈÀë×Ó£©£¬¸¹Ç»¾µÇ°ÁÐÏÙ°©¸ùÖÎÊõµÈ·½ÃæÑо¿£»... [Õ¹¿ª]


Ñо¿ÁìÓò£º Éó¤Ç°ÁÐÏÙ¼²²¡ÕïÖΣ¬ÓÈÆäרעǰÁÐÏÙØà³ýÊõ£¨¼¤¹âºÍµÈÀë×Ó£©£¬¸¹Ç»¾µÇ°ÁÐÏÙ°©¸ùÖÎÊõµÈ·½ÃæÑо¿£»Éó¤ÃÚÄòϵÖ×ÁöµÄ¸¹Ç»¾µÎ¢´´ÖÎÁÆÑо¿£»Éó¤ÃÚÄòϵ½áʯÕïÖΣ¨ÊäÄò¹ÜÈí¾µ¡¢Ó²¾µ¡¢¾­Æ¤Éö¾µ¼¼Êõ£©¡£ [ÊÕÆð]




¸öÈ˼òÊö :
ÕÅ־ΰ ÄÐ 39Ëê ҽѧ²©Ê¿£¬¸±Ö÷ÈÎҽʦ£¬´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚÒ»Ò½ÔºÃÚÄòÍâ¿Æ¹¤×÷¡£1996Äꡪ2001Äê £¬É½Î÷Ò½¿Æ´óѧ£¬ÁÙ´²Ò½Ñ§£¬Ñ§Ê¿Ñ§Î»£»2002Äꡪ2005Ä꣬´óÁ¬Ò½¿Æ´óѧ£¬Íâ¿Æѧ£¬Ë¶Ê¿ÑÐѧλ£»2011Äꡪ2015Ä꣬´óÁ¬Ò½¿Æ´óѧ£¬Íâ¿Æѧ£¬²©Ê¿Ñ§Î»¡£ÏÖÈÎÖйúÖÐÎ÷Ò½½áºÏѧ»áÃÚÄòÍâ¿Æ·Ö»áÈ«¹úÇàÄêίԱ£¬ÁÉÄþÊ¡ÖÐÎ÷Ò½½áºÏѧ»áÃÚÄòÍâ¿Æ·Ö»áίԱ£¬ÁÉÄþÊ¡ÃÚÄòÍâ¿Æ·Ö»áÇàÄêίԱ£¬´óÁ¬ÊÐÖÐÎ÷Ò½½áºÏѧ»áÃÚÄòÍâ¿Æ·Ö»áίԱ¡£

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿
1£©¡¢ÏîÄ¿Ãû³Æ¼°±àºÅ£ºPSMA°ÐÏò 18F-Glu-urea-R PET/CT ·Ö×Ó̽ÕëµÄºÏ³É¼°¶ÔÇ°ÁÐÏÙ°©Õï¶ÏµÄÑо¿£¨**£©×ÊÖú½ð¶î£º70ÍòÔª£»ÏîÄ¿Ö÷³ÖÈË£ºËÎϣ˫£»Á¢ÏîÄê¶È£º2012Äꣻ²¿ÃÅ£º¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£»¿ÎÌâ×éÖÐÅÅÃû£ºµÚ7λ¡£2£©¡¢ÏîÄ¿Ãû³Æ¼°±àºÅ£ºÈýÑõ»¯¶þÉéÓÕµ¼ÐÛ¼¤ËØ·ÇÒÀÀµÇ°ÁÐÏÙ°©µòÍöMAPKͨ·¼°VK3ЭͬӦÓõÄÑо¿£¨2012A002£©×ÊÖú½ð¶î£º80ÍòÔª£»ÏîÄ¿Ö÷³ÖÈË£º½ªÌΣ»Á¢ÏîÄê¶È£º2012Äꣻ²¿ÃÅ£º¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£» ¿ÎÌâ×éÖÐÅÅÃû£ºµÚ2λ¡£3£©¡¢ÏîÄ¿Ãû³Æ¼°±àºÅ£ºAquaporinˮͨµÀµ°°×ÔÚÇ°ÁÐÏÙ°©Öеıí´ï¼°Ô¤ºó¼à²âµÄÑо¿£¨2010C035£©×ÊÖú½ð¶î£º3ÍòÔª£»Á¢ÏîÄê¶È£º2010ÄꣻÁ¢ÏÃÅ£ºÁÉÄþÊ¡½ÌÓýÌü¼Æ»®ÏîÄ¿¿ÎÌâ×éÖÐÅÅÃû£ºµÚ5λ¡£4£©¡¢ÏîÄ¿Ãû³Æ¼°±àºÅ£ºmiRNA-21°ÐÏòPDCD4ÔÚÉö°©·¢Éú¡¢·¢Õ¹¼°Ô¤ºó¼à²â×÷ÓõÄÑо¿£¨**£©×ÊÖú½ð¶î£º5ÍòÔª£»Á¢ÏîÄê¶È£º2011ÄꣻÁ¢ÏÃÅ£ºÁÉÄþÊ¡¿Æ¼¼¼Æ»®ÏîÄ¿¡£¿ÎÌâ×éÖÐÅÅÃû£ºµÚ4λ¡£ 5£©¡¢ÏîÄ¿Ãû³Æ¼°±àºÅ£ºÉöϸ°û°©°ÐÏòÖÎÁƵÄÁÙ´²Ñо¿£¨2009E12SF165£© ×ÊÖú½ð¶î£º5ÍòÔª£»Á¢ÏîÄê¶È£º2009ÄꣻÁ¢ÏÃÅ£º´óÁ¬ÊпƼ¼¼Æ»®ÏîÄ¿¿ÎÌâ×éÖÐÅÅÃû£ºµÚ2λ¡£ 6£©¡¢ÏîÄ¿Ãû³Æ¼°±àºÅ£º³¬Éù΢Åݽ鵼VHL»ùÒòתȾ¸ÉÔ¤Éö·¢ÉúÓë·¢Õ¹µÄʵÑéÑо¿£¨**£© ×ÊÖú½ð¶î£º2ÍòÔª£»Á¢ÏîÄê¶È£º2008ÄꣻÁ¢ÏÃÅ£ºÁÉÄþÊ¡¿Æ¼¼¼Æ»®ÏîÄ¿¿ÎÌâ×éÖÐÅÅÃû£ºµÚ2λ¡£
ÎÄÕÂ
1£©¡¢Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancer. Oncology Letters. 2016 Aug12(2). 1001-1006.IF: 1.482.µÚÒ»×÷Õß.2)¡¢ Nodal activates smad and extracellular signal-regulated kinases 1/2 pathways promoting renal cell carcinoma proliferation. Mol Med Rep. 2015 Jul 12(1). 587-594. IF: 1.559.µÚÒ»×÷Õß.3)¡¢Admission markers predict lacunar and non-lacunar stroke in young patients. Thromb Res. 2011 128(1). 14-17. IF: 2.32.µÚÒ»×÷Õß.4)¡¢Ë÷À­·ÇÄáÖÎÁÆÍíÆÚÉö°©µÄ¶¾¸±×÷ÓúÍÓÐЧÐÔµÄÁÙ´²Ñо¿£¬Ò½Ñ§ÓëÕÜѧ£¬2013.7B£¬P52¡£µÚÒ»×÷Õß¡£